Hereditäre nicht-polypöse kolorektale Karzinome

Zusammenfassung

Etwa 20 – 25 % aller kolorektalen Karzinome treten familiär gehäuft auf. Bei 4 – 5 % ist die Familienanamnese positiv mit autosomal dominanter Vererbung. Erbliche kolorektale Karzinome sind grundsätzlich in adenomatöse, und die seltenen hyperplastischen, hamartomatösen bzw. juvenilen polypösen Erkrankungen zu differenzieren.

Familien mit hereditären nicht-polypösen kolorektalen Karzinomen (HNPCC; hereditary non-polyposis colorectal cancer) umfassen zwei Tumorentitäten. Zum einen Tumore mit Mikrosatelliteninstabilität und Keimbahnmutation in einem der DNA-Reparaturgene (MSI, Lynch-Syndrom) und zum anderen Tumore ohne Mikrosatelliteninstabilität (MSS). Familien mit Lynch-Syndrom weisen gegenüber Familien mit MSS-Tumoren zusätzliche assoziierte Tumorerkrankungen, ein früheres Erkrankungsalter und ein höheres Risiko für syn- und metachrone Zweitneoplasien auf.

Summary

Familial clusternig is found in 20–25% of all cases with colorectal cancer (CRC), 4–5% revealing autosomal dominant inheritance. Hereditary CRC develops from adenomatous, hyperplastic hamartomatous juvenile lesions. Hereditory nonpolyposis colorectal cancer includes two genetically different tumor entities, those with and without microsatellite instability in the corresponding tumors. Those with such instability and with germ-line mutation in DNA mismatch repair genes (Lynch syndrome) have additional neoplasms, an earlier age at onset and a higher risk for syn- and metachronous cancers.

erbliche kolorektale Karzinome - HNPCC - FAP - Polyposis

hereditary colorectal cancer - HNPCC - FAP - polyposis

Literatur

• 1 Boland C R, Thibodeau S N, Hamilton S R. et al . A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.  Cancer Res. 1998;  58 5248-5257
• 2 Dove-Edwin I, de Jong A E, Adams J. et al . Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.  Gastroenterology. 2006;  130 1995-2000
• 3 Engel C, Forberg J, Holinski-Feder E. et al . Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer.  Int J Cancer. 2006;  118 115-122
• 4 Goecke T, Schulmann K, Engel C. et al . Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium.  J Clin Oncol. 2006;  24 4285-4292
• 5 Hampel H, Stephens J A, Pukkala E. et al . Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.  Gastroenterology. 2005;  129 415-421
• 6 Herman J G, Umar A, Polyak K. et al . Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.  Proc Natl Acad Sci U S A. 1998;  95 6870-6875
• 7 Hitchins M P, Wong J J, Suthers G. et al . Inheritance of a cancer-associated MLH1 germ-line epimutation.  N Engl J Med. 2007;  356 697-705
• 8 Johns L E, Houlston R S. A systematic review and meta-analysis of familial colorectal cancer risk.  Am J Gastroenterol. 2001;  96 2992-3003
• 9 Kuismanen S A, Holmberg M T, Salovaara R, de la Chapelle A, Peltomaki P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.  Am J Pathol. 2000;  156 1773-1779
• 10 Lindor N M, Rabe K, Petersen G M. et al . Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.  JAMA. 2005;  293 1979-1985
• 11 Morak M, Schackert H K, Rahner N. et al . Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.  Eur J Hum Genet. 2008;  16 (7) 804-811
• 12 Mueller-Koch Y, Vogelsang H, Kopp R. et al . Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer.  Gut. 2005;  54 1733-1740
• 13 Olsson L, Lindblom A. Family history of colorectal cancer in a Sweden county.  Fam Cancer. 2003;  2 87-93
• 14 Renkonen-Sinisalo L, Butzow R, Leminen A, Lehtovirta P, Mecklin J P, Jarvinen H J. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome.  Int J Cancer. 2007;  120 821-824
• 15 Salovaara R, Loukola A, Kristo P. et al . Population-based molecular detection of hereditary nonpolyposis colorectal cancer.  J Clin Oncol. 2000;  18 2193-2200
• 16 St John D J, McDermott F T, Hopper J L, Debney E A, Johnson W R, Hughes E S. Cancer risk in relatives of patients with common colorectal cancer.  Ann Intern Med. 1993;  118 785-790
• 17 Umar A, Boland C R, Terdiman J P. et al . Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.  J Natl Cancer Inst. 2004;  96 261-268
• 18 Vasen H F, Mecklin J P, Khan P M, Lynch H T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).  Dis Colon Rectum. 1991;  34 424-425
• 19 Vasen H F, Moslein G, Alonso A. et al . Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).  J Med Genet. 2007;  44 353-362
• 20 Vasen H F, Taal B G, Nagengast F M. et al . Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families.  Eur J Cancer. 1995;  31A 1145-1148
• 21 Vasen H F, Watson P, Mecklin J P, Lynch H T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.  Gastroenterology. 1999;  116 1453-1456
• 22 Vasen H F, Wijnen J T, Menko F H. et al . Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.  Gastroenterology. 1996;  110 1020-1027
• 23 Watson P, Vasen H F, Mecklin J P. et al . The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.  Int J Cancer. 2008;  123 444-449